Olanzapine 10 mg tablets recalled due to cGMP deviations
Macleods Pharma USA is voluntarily recalling Olanzapine 10 mg tablets nationwide due to cGMP (current good manufacturing practices) deviations identified during manufacturing. The recall affects 3,672 bottles distributed across the United States.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for cGMP deviations—manufacturing quality control issues. The source text does not report any illnesses, injuries, or hospitalizations. Per the rubric, Class II recalls without reported adverse events typically score as Moderate (2).
Plain-English summary
Macleods Pharma USA Inc is voluntarily recalling Olanzapine Tablets, USP 10 mg in 30-count bottles due to cGMP deviations. The product was manufactured by Macleods Pharmaceuticals Ltd. in Baddi, Himachal Pradesh, India, and distributed nationwide within the United States.
The recall includes 3,672 bottles with lot numbers BOB42029A and BOB4202B, with an expiration date of 09/2022. The affected NDC number is 33342-070-07. The recall was initiated on February 16, 2022, following the firm's discovery of manufacturing deviations and was classified as FDA Class II on February 28, 2022.
Patients currently taking this medication should contact their healthcare provider or pharmacist for guidance. Do not stop taking olanzapine without medical advice, as abruptly discontinuing antipsychotic medication can be harmful. Patients should ask their pharmacist whether their specific medication is part of this recall.
The recalled product
- Product
- OLANZAPINE (OLANZAPINE)
- Brand
- OLANZAPINE
- Manufacturer
- Macleods Pharma Usa Inc
- Hazard
- cgmp-deviation
- manufacturing-quality
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #: BOB42029A
- BOB4202B
- Exp. Date 09/2022
UPCs (6)
- 0333342067074
- 0333342070074
- 0333342069078
- 0333342072078
- 0333342071071
- 0333342068071
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · OLANZAPINE
- ModerateOlanzapine 2.5 mg Tablets Recalled for Failed Impurity Specifications
FDA (Drugs) · 2024-12-25
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27